Natural History Studies
Utilise observational data to characterise the untreated progression of a disease, establishing a reference for treatment efficacy assessment
Reduce drug development timelines, lower costs and make informed decisions using RWE
Utilise observational data to characterise the untreated progression of a disease, establishing a reference for treatment efficacy assessment
At Inovia Bio, we leverage our proprietary technology and regulatory expertise to create personalised solutions for each of our partners.
We start by working closely with your team to deeply understand your unique challenges and desired outcomes, laying a solid foundation for a tailored, data-driven strategy.
Within just 7 days, we deliver an Integrated Evidence Plan via InovaIEP that aligns all stakeholders, identifies critical evidence gaps, and defines the precise data needed to support your asset’s regulatory journey.
Using Inova360, we identify the necessary regulatory-grade RWD to support your submission in minutes, ensuring speed and precision every step of the way.
With InovaMine, we maximise your RWE data, transforming it into actionable insights that empower you to make informed decisions and strengthen your program
Our experienced Medical Team guides you throughout the regulatory process, proactively identifying potential issues and ensuring a seamless path to success.
Design RWE studies in Minutes, specifically outlining the windows for assessing various aspects of the study cohort